ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity

ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity

The aim of the present study was to assess the ABO blood group polymorphism association with prostate, bladder and kidney cancer, and longevity. The following data groups were analyzed: Prostate cancer (n=2,200), bladder cancer (n=1,530), renal cell cancer (n=2,650), oldest-old (n=166) and blood don...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology letters 2018-07, Vol.16 (1), p.1321-1331
Hauptverfasser: Stakišaitis, Donatas, Juknevičienė, Milda, Ulys, Albertas, Žaliūnienė, Dalia, Stanislovaitienė, Daiva, Šepetienė, Ramunė, Slavinska, Anželika, Sužiedėlis, Kęstutis, Lesauskaitė, Vita
Format: Artikel
Sprache:eng
Schlagworte:
ABO blood-group system
Antigens
Bladder cancer
Blood & organ donations
Blood groups
Carbohydrates
Carcinogenesis
Cluster analysis
Confidence intervals
Gene expression
Genetic aspects
Genetic polymorphisms
Health aspects
Kidney cancer
Medical research
Mortality
Oldest old people
Pathogenesis
Population
Prostate cancer
Researchers
Studies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The aim of the present study was to assess the ABO blood group polymorphism association with prostate, bladder and kidney cancer, and longevity. The following data groups were analyzed: Prostate cancer (n=2,200), bladder cancer (n=1,530), renal cell cancer (n=2,650), oldest-old (n=166) and blood donors (n=994) groups. The data on the ABO blood type frequency and odds ratio in prostate cancer patients revealed a significantly higher blood group B frequency (P
ISSN:1792-1074
1792-1082
DOI:10.3892/ol.2018.8749